快感缺失的炎症机制研究进展

doi:10.3969/j.issn.1674-8115.2021.02.018

上海交通大学学报(医学版) ›› 2021, Vol. 41 ›› Issue (2): 241-245.doi: 10.3969/j.issn.1674-8115.2021.02.018

快感缺失的炎症机制研究进展

吴则南(), 张晨()

上海交通大学医学院附属精神卫生中心生化药理研究室，上海 200030

收稿日期:2020-02-14 出版日期:2021-02-28 发布日期:2021-02-28
通讯作者: 张晨 E-mail:zenan_wu@163.com;zhangchen645@gmail.com
作者简介:吴则南（1996—），男，硕士生；电子信箱：zenan_wu@163.com。
基金资助:
国家重点研发计划(2018YFC1314302);国家自然科学基金(81471358);上海市科学技术委员会西医引导类项目(19411969300);上海市教育委员会高峰高原学科建设计划(20152530)

Research advances in inflammatory mechanism of anhedonia

Ze-nan WU(), Chen ZHANG()

Biochemical Pharmacology Laboratory, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China

Received:2020-02-14 Online:2021-02-28 Published:2021-02-28
Contact: Chen ZHANG E-mail:zenan_wu@163.com;zhangchen645@gmail.com
Supported by:
National Key Research and Development Program of China(2018YFC1314302);National Natural Science Foundation of China(81471358);Western Medicine Guide Project of Science and Technology Commission of Shanghai Municipality(19411969300);Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20152530)

摘要/Abstract

摘要：

快感缺失存在于多种精神疾病，是预测患者转归的重要指标。完善快感缺失的概念，深入探究其机制，从而进一步明确其病理生理学基础，有利于相关疾病的诊断和治疗。近年来，大量研究表明机体炎症状态下犬尿氨酸途径与四氢生物蝶呤代谢的异常会导致奖赏环路神经损伤和递质紊乱，与快感缺失的发生和发展密切相关。该文以此为重点，对快感缺失炎症机制的研究进展进行综述。

关键词: 快感缺失, 奖赏回路, 炎症, 犬尿氨酸途径, 四氢生物蝶呤

Abstract:

Anhedonia, a typical symptom of many mental diseases, is also an important indicator for treatment outcome. Further exploration of the mechanism of anhedonia and clear definition and illustration of its pathophysiological basis are helpful to the diagnosis and treatment of related diseases. In recent years, converging evidence has implicated that inflammation-driven alterations in kynurenine pathway (KP) and tetrahydrobiopterin (BH4) metabolism lead to nerve injury and disturbance of neurotransmitter in reward circuit, which is closely related to the emergence and development of anhedonia. Therefore, this review aims to summarize the research advances in the inflammatory mechanism of anhedonia, with the emphasis on both KP and BH4 metabolism.

Key words: anhedonia, reward circuit, inflammation, kynurenine pathway, tetrahydrobiopterin

中图分类号:

吴则南, 张晨. 快感缺失的炎症机制研究进展[J]. 上海交通大学学报(医学版), 2021, 41(2): 241-245.

Ze-nan WU, Chen ZHANG. Research advances in inflammatory mechanism of anhedonia[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 241-245.

参考文献 39

1	Kendler KS. The phenomenology of major depression and the representativeness and nature of DSM criteria[J]. Am J Psychiatry, 2016, 173(8): 771-780.
2	Bennik EC, Nederhof E, Ormel J, et al. Anhedonia and depressed mood in adolescence: course, stability, and reciprocal relation in the TRAILS study[J]. Eur Child Adolesc Psychiatry, 2014, 23(7): 579-586.
3	Winer ES, Nadorff MR, Ellis TE, et al. Anhedonia predicts suicidal ideation in a large psychiatric inpatient sample[J]. Psychiatry Res, 2014, 218(1-2): 124-128.
4	Barch DM, Whalen D, Gilbert K, et al. Neural indicators of anhedonia: predictors and mechanisms of treatment change in a randomized clinical trial in early childhood depression[J]. Biol Psychiatry, 2019, 85(10): 863-871.
5	Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression[J]. Mol Psychiatry, 2016, 21(10): 1358-1365.
6	Boyle CC, Kuhlman KR, Dooley LN, et al. Inflammation and dimensions of reward processing following exposure to the influenza vaccine[J]. Psychoneuroendocrinology, 2019, 102: 16-23.
7	Murakami Y, Ishibashi T, Tomita E, et al. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2, 3-dioxygenase 1[J]. Sci Rep, 2016, 6: 29920.
8	Bergamini G, Mechtersheimer J, Azzinnari D, et al. Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice[J]. Neurobiol Stress, 2018, 8: 42-56.
9	Rømer Thomsen K, Whybrow PC, Kringelbach ML. Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain[J]. Front Behav Neurosci, 2015, 9: 49.
10	Zhang B, Lin P, Shi HQ, et al. Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis[J]. Brain Imaging Behav, 2016, 10(3): 920-939.
11	Freed RD, Mehra LM, Laor D, et al. Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions[J]. World J Biol Psychiatry, 2019, 20(9): 712-722.
12	Szczypiński JJ, Gola M. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?[J]. Rev Neurosci, 2018, 29(7): 727-744.
13	Wenzel JM, Cheer JF. Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling[J]. Neuropsychopharmacology, 2018, 43(1): 103-115.
14	Yan C, Yang T, Yu QJ, et al. Rostral medial prefrontal dysfunctions and consummatory pleasure in schizophrenia: a meta-analysis of functional imaging studies[J]. Psychiatry Res, 2015, 231(3): 187-196.
15	Der-Avakian A, D'Souza MS, Potter DN, et al. Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats[J]. Psychopharmacology (Berl), 2017, 234(9-10): 1603-1614.
16	Yin LJ, Xu XD, Chen G, et al. Inflammation and decreased functional connectivity in a widely-distributed network in depression: centralized effects in the ventral medial prefrontal cortex[J]. Brain Behav Immun, 2019, 80: 657-666.
17	Felger JC, Mun J, Kimmel HL, et al. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates[J]. Neuropsychopharmacology, 2013, 38(11): 2179-2187.
18	Felger JC, Hernandez CR, Miller AH. Levodopa reverses cytokine-induced reductions in striatal dopamine release[J]. Int J Neuropsychopharmacol, 2015, 18(4): pyu084.
19	Kim H, Chen L, Lim G, et al. Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression[J]. J Clin Invest, 2012, 122(8): 2940-2954.
20	Salazar F, Hall L, Negm OH, et al. The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2, 3-dioxygenase axis in dendritic cells affecting T helper cell polarization[J]. J Allergy Clin Immunol, 2016, 137(6): 1841-1851.e2.
21	Rodrigues FTS, de Souza MRM, Lima CNC, et al. Major depression model induced by repeated and intermittent lipopolysaccharide administration: long-lasting behavioral, neuroimmune and neuroprogressive alterations[J]. J Psychiatr Res, 2018, 107: 57-67.
22	Xie W, Cai L, Yu YH, et al. Activation of brain indoleamine 2, 3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy[J]. J Neuroinflammation, 2014, 11: 41.
23	Walker AK, Budac DP, Bisulco S, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice[J]. Neuropsychopharmacology, 2013, 38(9): 1609-1616.
24	Laumet G, Zhou WJ, Dantzer R, et al. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain[J]. Brain Behav Immun, 2017, 66: 94-102.
25	Schwarz MJ, Guillemin GJ, Teipel SJ, et al. Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls[J]. Eur Arch Psychiatry Clin Neurosci, 2013, 263(4): 345-352.
26	Monteggia LM, Gideons E, Kavalali ET. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine[J]. Biol Psychiatry, 2013, 73(12): 1199-1203.
27	Gill JS, Jamwal S, Kumar P, et al. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: possible neurotransmitters modulation[J]. Pharmacol Rep, 2017, 69(2): 306-313.
28	Haroon E, Chen XC, Li ZH, et al. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia[J]. Transl Psychiatry, 2018, 8(1): 189.
29	Beggiato S, Tanganelli S, Fuxe K, et al. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex[J]. Neuropharmacology, 2014, 82: 11-18.
30	Savitz J, Drevets WC, Smith CM, et al. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder[J]. Neuropsychopharmacology, 2015, 40(2): 463-471.
31	Vichaya EG, Laumet G, Christian DL, et al. Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2, 3 dioxygenase[J]. Neuropsychopharmacology, 2019, 44(2): 364-371.
32	Antoniades C, Cunnington C, Antonopoulos A, et al. Induction of vascular GTP-cyclohydrolase Ⅰ and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis[J]. Circulation, 2011, 124(17): 1860-1870.
33	Strasser B, Sperner-Unterweger B, Fuchs D, et al. Mechanisms of inflammation-associated depression: immune influences on tryptophan and phenylalanine metabolisms[J]. Curr Top Behav Neurosci, 2017, 31: 95-115.
34	Neurauter G, Schröcksnadel K, Scholl-Bürgi S, et al. Chronic immune stimulation correlates with reduced phenylalanine turnover[J]. Curr Drug Metab, 2008, 9(7): 622-627.
35	Capuron L, Schroecksnadel S, Féart C, et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms[J]. Biol Psychiatry, 2011, 70(2): 175-182.
36	Felger JC, Li L, Marvar PJ, et al. Tyrosine metabolism during interferon-α administration: association with fatigue and CSF dopamine concentrations[J]. Brain Behav Immun, 2013, 31: 153-160.
37	Haruki H, Hovius R, Pedersen MG, et al. Tetrahydrobiopterin biosynthesis as a potential target of the kynurenine pathway metabolite xanthurenic acid[J]. J Biol Chem, 2016, 291(2): 652-657.
38	Sas K, Szabó E, Vécsei L. Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection[J]. Molecules, 2018, 23(1): E191.
39	Felger JC, Treadway MT. Inflammation effects on motivation and motor activity: role of dopamine[J]. Neuropsychopharmacology, 2017, 42(1): 216-241.

[1]	郭林秀美, 章一新. 皮肤自体荧光检测技术在疾病诊断中的应用[J]. 上海交通大学学报(医学版), 2021, 41(2): 251-256.
[2]	陈帅1，丁风华2，代杨1，陆林2，沈迎2，沈卫峰2. 炎症细胞参与侧支循环形成的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(3): 380-.
[3]	周铖1，孙鹏飞2，尹继瑶3，王阳阳1，肖海娟4, 5. 粪菌移植治疗炎症性肠病的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(2): 267-.
[4]	胡苡1, 2，周薇2，宋忠臣1, 2. 实验性牙周炎大鼠脑内外的炎性改变[J]. 上海交通大学学报(医学版), 2020, 40(12): 1579-1584.
[5]	王立峰，陈俊杰，李永宁，王玲，王磊，李雪娇. 姜黄素对心脏停搏/心肺复苏大鼠肠黏膜损伤的抑制作用[J]. 上海交通大学学报(医学版), 2020, 40(12): 1607-1613.
[6]	曹力元，牟为. 程序性坏死的诱导剂和抑制剂及其在疾病中作用的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(11): 1524-1529.
[7]	王齐1，朱冠娅2，谢挺1，葛奎1，牛轶雯3. ATP代谢及嘌呤信号受体在糖尿病创面愈合炎症反应阶段的变化[J]. 上海交通大学学报（医学版）, 2020, 40(1): 10-.
[8]	余玲芳1，方新宇2，陈艳1，王丹丹1，汪也微1，吴则南1，刘瑞梅1，张晨1. 精神分裂症快感缺失特征及其影响因素分析[J]. 上海交通大学学报(医学版), 2020, 40(09): 1207-1212.
[9]	李森1，贾子衡1，魏雪睿1，马赛1，卢天成1，李婷婷2，顾燕云2. 胆汁酸的代谢稳态调控作用综述[J]. 上海交通大学学报(医学版), 2020, 40(08): 1126-1130.
[10]	李月1, 2，孙寒晓2，殳洁2，李咏梅1#，盛慧明2#. 利拉鲁肽作用肠道固有淋巴细胞改善小鼠炎症性肠病[J]. 上海交通大学学报(医学版), 2020, 40(06): 744-751.
[11]	储维薇，徐洁颖，李尚，翟君钰，杜艳芝. 脱氢表雄酮诱导的多囊卵巢综合征模型大鼠的肠道菌群研究[J]. 上海交通大学学报（医学版）, 2019, 39(9): 975-.
[12]	陆海洋，赵维莅. 胃肠道微生物在肿瘤发生中的作用[J]. 上海交通大学学报（医学版）, 2019, 39(9): 1083-.
[13]	龙泉 1，秦纪平 2，李蓉 2，常娟 2，蒋更如 3，朱淳 2, 3. 血液透析联合血液灌流治疗维持性血透患者的效果观察[J]. 上海交通大学学报（医学版）, 2019, 39(8): 886-.
[14]	谢小华 1，陈泽 1，刘成博 1，杨奕辉 2，张拥军 1. 鲨肝醇对支气管肺发育不良新生大鼠肺泡化阻滞的改善作用[J]. 上海交通大学学报（医学版）, 2019, 39(7): 714-.
[15]	王昊 1，江杉 1，龚杨明 2，刘燕 3，华丽 1，邓晓蓓 1. 大气细颗粒物通过嗅球途径导致阿尔茨海默病的机制研究进展[J]. 上海交通大学学报（医学版）, 2019, 39(6): 666-.

快感缺失的炎症机制研究进展

Research advances in inflammatory mechanism of anhedonia

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

编辑推荐

Metrics